Development of Chromenopyrazole-Based Selective Cannabinoid 2 Receptor Agonists
Sameek Singh, Ian Liddle, Christa Macdonald, Joel D. A. Tyndall, Michelle Glass, Andrea J. Vernall
Compounds that bind to and activate cannabinoid receptors are typically very lipophilic. We have developed a series of more polar ligands that are high-affinity, selective cannabinoid type 2 receptor activators. These ligands will be useful tools to probe cannabinoid receptor function and location.
Source: Australian Journal of Chemistry - Category: Chemistry Authors: Sameek Singh Ian Liddle Christa Macdonald Joel D. A. Tyndall Michelle Glass Andrea J. Vernall Source Type: research
More News: Australia Health | Chemistry